Brief Report
Potential role of Lu/BCAM in HIV-related atherosclerosis
African Journal of Laboratory Medicine | Vol 8, No 1 | a792 |
DOI: https://doi.org/10.4102/ajlm.v8i1.792
| © 2019 Modisa S. Motswaledi, Ishmael Kasvosve, Oluwafemi O. Oguntibeju
| This work is licensed under CC Attribution 4.0
Submitted: 16 February 2018 | Published: 30 September 2019
Submitted: 16 February 2018 | Published: 30 September 2019
About the author(s)
Modisa S. Motswaledi, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa; and, Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, BotswanaIshmael Kasvosve, Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana
Oluwafemi O. Oguntibeju, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa
Abstract
Atheromatous lesions are formed by macrophages and low-density lipoprotein cholesterol invading the vascular intima. Here we show that increasing cholesterol levels are associated with peripheral monocyte depletion and this imbalance is aggravated by carriage of Lu/BCAM leukocyte adhesion molecules. This is true only in HIV infection and probably explains the risk of atherosclerosis observed in HIV-positive patients.
Keywords
cholesterol; Non-high-density lipoprotein cholesterol; Lu/BCAM; Atherosclerosis
Metrics
Total abstract views: 2709Total article views: 3416